At a glance
ClinicalIndex Comparison RecordN/ACompleted· 114,921 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment of the Oxygen Use and Future Outcomes Associated With Oxygen Use in Patient With Fibrotic ILD
In Brief
An observational study for Lung Diseases, Interstitial. Completed, enrolled 114,921 participants across 1 site.
Detailed Summary
The purpose of this study is to describe initiation and use of oxygen therapy among patients with fibrotic Interstitial Lung Disease (ILD) and to assess the impact of oxygen therapy on clinical outcomes among patients with fibrotic ILD.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLung Diseases, Interstitial
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
First PostedJul 2023
Enrollment StartJul 2023
Primary CompletionSep 2023
TodayJul 2026
First PostedJul 24, 2023
Enrollment StartJul 25, 2023
Primary CompletionSep 26, 2023
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 2.9 years ago